SlideShare a Scribd company logo
 The new initiative is focused on gene therapy. Pfizer operates a gene
therapy research facility at the Sanford complex.
 “The new facility will help advance Pfizer’s work in researching highly
specialized, potentially one-time gene therapy treatments that use custom-
made adeno-associated virus (AAV) vectors to deliver treatment effectively
to patients” according to Pfizer.
Pfizer to announce more jobs, investment at
Sanford, NC plant
 Pfizer, the world’s largest drugmaker, plans to divest its off-patent drug
business and combine it with generic-drug maker Mylan.
 Under the agreement, which is structured as an all-stock deal, each Mylan
share would be converted into one share of the new company.
 Pfizer shareholders would own 57% of the combined new company and
Mylan shareholders would own 43%, Mylan said.
Pfizer will combine its off-patent drug business
with Mylan
 Pfizer announced in mid-June that it would buy Array (ARRY) in a deal
worth a reported $10.6 billion.
Pfizer acquires Array BioPharma
 The FDA has approved Pfizer’s rituximab biosimilar, Ruxience (rituximab-pvvr),
referencing Rituxan. The biosimilar was approved to treat non-Hodgkin lymphoma,
chronic lymphocytic leukemia, and granulomatosis with polyangiitis and
microscopic polyangiitis.
 The fact that the biosimilar was not approved for all indications of its reference, a
Pfizer representative told The Center for Biosimilars® in an email, is due to the fact
that “Genentech has exclusivity for rituximab in certain indications. Pfizer has
agreed to the terms of a global settlement,” but “specific terms and conditions of
the settlement are confidential.”
FDA Approves Pfizer's Rituximab Biosimilar,
Ruxience
 Pfizer Inc said it acquired a 15 percent stake in Vivet Therapeutics, as well
as an exclusive option to fully acquire it, a deal that will give it access to
the French company’s experimental gene therapy for a rare genetic
disorder called Wilson disease.
 Pfizer has paid Vivet about $51 million upfront and may pay up to $635.8
million in clinical, regulatory milestone payments and to exercise the
option to buy the whole company.
Pfizer buys stake in French gene therapy firm
Vivet
 The U.S. Food and Drug Administration approved Pfizer Inc’s oral drug,
tafamidis, to treat a rare and fatal heart disease called transthyretin
amyloid cardiomyopathy.
 Pfizer, which has touted tafamidis as a potential blockbuster product, set a
list price of $225,000 a year for the medicine, which would be sold under
the brand name Vyndaqel.
The U.S. Food and Drug Administration approved
Pfizer Inc’s oral drug, tafamidis
 More than three years after snapping up Hospira, Pfizer has finally
decided that some of its manufacturing facilities in India are beyond
redemption.
 The U.S. pharma will shut down its long-troubled injectables facility in
Irungattukottai, India, as well as another site in Aurangabad, India, both of
which were folded into Pfizer through the $15 billion acquisition of Hospira
in 2015.
Pfizer will shut down its injectables facility in
Irungattukottai, India, as well as another site in
Aurangabad, India
The Pfizer TURBO report has dozens of pages of customer insights
compiled to help you sell and market more effectively.
FORTUNE 500 TURBO REPORTS
844.DATABAHN
844.328.2224 ext. 707
info@databahn.com
www.databahn.com
We help sales reps and marketers eliminate costly research time and
uncover new sales pipeline opportunities.
Please visit www.databahn.com/page/turbo to download a TURBO Fortune
500 company profile report (PDF).
We also build custom deep dive Fortune 1000 company profile reports.
Please contact us if you need help.

More Related Content

What's hot

Pharma Uptoday Monthly Magazine - Volume 11, Issue Feb 2015
Pharma Uptoday Monthly Magazine - Volume 11, Issue Feb 2015Pharma Uptoday Monthly Magazine - Volume 11, Issue Feb 2015
Pharma Uptoday Monthly Magazine - Volume 11, Issue Feb 2015
Sathish Vemula
 
Drug Therapy Issues
Drug Therapy IssuesDrug Therapy Issues
Drug Therapy Issues
MichaelJoseph167
 
Module 2 Final June 2007
Module 2 Final June 2007Module 2 Final June 2007
Module 2 Final June 2007
Flavio Guzmán
 
Drugs approved in 2010
Drugs approved in 2010Drugs approved in 2010
Drugs approved in 2010
Naveen Kumar
 
Pharma Uptoday Monthly Magazine Volume 13, Issue Apr - 2015
Pharma Uptoday Monthly Magazine Volume 13, Issue Apr - 2015Pharma Uptoday Monthly Magazine Volume 13, Issue Apr - 2015
Pharma Uptoday Monthly Magazine Volume 13, Issue Apr - 2015
Sathish Vemula
 
Pharma Uptoday Monthly Magazine - Volume 19; issue: Oct 2015
Pharma Uptoday Monthly Magazine - Volume 19; issue: Oct 2015Pharma Uptoday Monthly Magazine - Volume 19; issue: Oct 2015
Pharma Uptoday Monthly Magazine - Volume 19; issue: Oct 2015
Sathish Vemula
 
Drl analysis
Drl analysisDrl analysis
Drl analysis
Bibhu Prasad
 
Pharma Uptoday Monthly Magazine Volume 12; Issue Mar 2015
Pharma Uptoday Monthly Magazine Volume 12; Issue Mar 2015Pharma Uptoday Monthly Magazine Volume 12; Issue Mar 2015
Pharma Uptoday Monthly Magazine Volume 12; Issue Mar 2015
Sathish Vemula
 
FIXED DOSE COMBINATIONS BANNED IN INDIA
FIXED DOSE COMBINATIONS BANNED IN INDIAFIXED DOSE COMBINATIONS BANNED IN INDIA
FIXED DOSE COMBINATIONS BANNED IN INDIA
JAYA PRAKASH VELUCHURI
 
Fixed dose combination products – rationality, status in india, development i...
Fixed dose combination products – rationality, status in india, development i...Fixed dose combination products – rationality, status in india, development i...
Fixed dose combination products – rationality, status in india, development i...
Dr Sukanta sen
 
Novartis india
Novartis indiaNovartis india
Novartis india
Himanshu Tripathi
 
FDC Ban - What's Right and What's Wrong?
FDC Ban - What's Right and What's Wrong?FDC Ban - What's Right and What's Wrong?
FDC Ban - What's Right and What's Wrong?
Anup Soans
 
Dr Reddys Analysis V1.1
Dr Reddys Analysis V1.1Dr Reddys Analysis V1.1
Dr Reddys Analysis V1.1
Puneet_Piyush
 
Generic prescribing akmccc
Generic prescribing  akmcccGeneric prescribing  akmccc
Generic prescribing akmccc
Orgonic Baba
 
Ban of Fixed Dose Combination on India Impact and Implications
Ban of Fixed Dose Combination on India Impact and ImplicationsBan of Fixed Dose Combination on India Impact and Implications
Ban of Fixed Dose Combination on India Impact and Implications
ijtsrd
 
Qui Tam: Off Label Drug Marketing [Data Snapshot]
Qui Tam: Off Label Drug Marketing [Data Snapshot]Qui Tam: Off Label Drug Marketing [Data Snapshot]
Qui Tam: Off Label Drug Marketing [Data Snapshot]
lawsuitlegal
 
Evaluate California Pharma & Biotech Innovation Outlook 2017
Evaluate California Pharma & Biotech Innovation Outlook 2017Evaluate California Pharma & Biotech Innovation Outlook 2017
Evaluate California Pharma & Biotech Innovation Outlook 2017
Evaluate Ltd
 
INVESTIGATIONAL NEW DRUG APPLICATION
INVESTIGATIONAL NEW DRUG APPLICATIONINVESTIGATIONAL NEW DRUG APPLICATION
INVESTIGATIONAL NEW DRUG APPLICATION
Bindu Kshtriya
 
A Study of generic drugs
A Study of generic drugsA Study of generic drugs
A Study of generic drugs
Santosh Salgare
 
Benjamin Roin, "Dormant Therapies"
Benjamin Roin, "Dormant Therapies"Benjamin Roin, "Dormant Therapies"

What's hot (20)

Pharma Uptoday Monthly Magazine - Volume 11, Issue Feb 2015
Pharma Uptoday Monthly Magazine - Volume 11, Issue Feb 2015Pharma Uptoday Monthly Magazine - Volume 11, Issue Feb 2015
Pharma Uptoday Monthly Magazine - Volume 11, Issue Feb 2015
 
Drug Therapy Issues
Drug Therapy IssuesDrug Therapy Issues
Drug Therapy Issues
 
Module 2 Final June 2007
Module 2 Final June 2007Module 2 Final June 2007
Module 2 Final June 2007
 
Drugs approved in 2010
Drugs approved in 2010Drugs approved in 2010
Drugs approved in 2010
 
Pharma Uptoday Monthly Magazine Volume 13, Issue Apr - 2015
Pharma Uptoday Monthly Magazine Volume 13, Issue Apr - 2015Pharma Uptoday Monthly Magazine Volume 13, Issue Apr - 2015
Pharma Uptoday Monthly Magazine Volume 13, Issue Apr - 2015
 
Pharma Uptoday Monthly Magazine - Volume 19; issue: Oct 2015
Pharma Uptoday Monthly Magazine - Volume 19; issue: Oct 2015Pharma Uptoday Monthly Magazine - Volume 19; issue: Oct 2015
Pharma Uptoday Monthly Magazine - Volume 19; issue: Oct 2015
 
Drl analysis
Drl analysisDrl analysis
Drl analysis
 
Pharma Uptoday Monthly Magazine Volume 12; Issue Mar 2015
Pharma Uptoday Monthly Magazine Volume 12; Issue Mar 2015Pharma Uptoday Monthly Magazine Volume 12; Issue Mar 2015
Pharma Uptoday Monthly Magazine Volume 12; Issue Mar 2015
 
FIXED DOSE COMBINATIONS BANNED IN INDIA
FIXED DOSE COMBINATIONS BANNED IN INDIAFIXED DOSE COMBINATIONS BANNED IN INDIA
FIXED DOSE COMBINATIONS BANNED IN INDIA
 
Fixed dose combination products – rationality, status in india, development i...
Fixed dose combination products – rationality, status in india, development i...Fixed dose combination products – rationality, status in india, development i...
Fixed dose combination products – rationality, status in india, development i...
 
Novartis india
Novartis indiaNovartis india
Novartis india
 
FDC Ban - What's Right and What's Wrong?
FDC Ban - What's Right and What's Wrong?FDC Ban - What's Right and What's Wrong?
FDC Ban - What's Right and What's Wrong?
 
Dr Reddys Analysis V1.1
Dr Reddys Analysis V1.1Dr Reddys Analysis V1.1
Dr Reddys Analysis V1.1
 
Generic prescribing akmccc
Generic prescribing  akmcccGeneric prescribing  akmccc
Generic prescribing akmccc
 
Ban of Fixed Dose Combination on India Impact and Implications
Ban of Fixed Dose Combination on India Impact and ImplicationsBan of Fixed Dose Combination on India Impact and Implications
Ban of Fixed Dose Combination on India Impact and Implications
 
Qui Tam: Off Label Drug Marketing [Data Snapshot]
Qui Tam: Off Label Drug Marketing [Data Snapshot]Qui Tam: Off Label Drug Marketing [Data Snapshot]
Qui Tam: Off Label Drug Marketing [Data Snapshot]
 
Evaluate California Pharma & Biotech Innovation Outlook 2017
Evaluate California Pharma & Biotech Innovation Outlook 2017Evaluate California Pharma & Biotech Innovation Outlook 2017
Evaluate California Pharma & Biotech Innovation Outlook 2017
 
INVESTIGATIONAL NEW DRUG APPLICATION
INVESTIGATIONAL NEW DRUG APPLICATIONINVESTIGATIONAL NEW DRUG APPLICATION
INVESTIGATIONAL NEW DRUG APPLICATION
 
A Study of generic drugs
A Study of generic drugsA Study of generic drugs
A Study of generic drugs
 
Benjamin Roin, "Dormant Therapies"
Benjamin Roin, "Dormant Therapies"Benjamin Roin, "Dormant Therapies"
Benjamin Roin, "Dormant Therapies"
 

Similar to 7 keys to open doors at Pfizer

Merger & Acquisition Deal Analysis
Merger & Acquisition Deal AnalysisMerger & Acquisition Deal Analysis
Merger & Acquisition Deal Analysis
RBSA Advisors
 
BioAnalysis_April 2016_Introducing The PfizerKline Empire_Raj Gunashekar
BioAnalysis_April 2016_Introducing The PfizerKline Empire_Raj GunashekarBioAnalysis_April 2016_Introducing The PfizerKline Empire_Raj Gunashekar
BioAnalysis_April 2016_Introducing The PfizerKline Empire_Raj Gunashekar
Raj Gunashekar
 
Pharma Spectrum by OPPI
Pharma Spectrum by OPPIPharma Spectrum by OPPI
Pharma Spectrum by OPPI
Anup Soans
 
Case study.pptx
Case study.pptxCase study.pptx
Case study.pptx
AnadiJangra
 
ANDA FDA APPLICATION
ANDA FDA APPLICATIONANDA FDA APPLICATION
ANDA FDA APPLICATION
Roshan Bodhe
 
Pfizer_Market_overview .pptx
Pfizer_Market_overview .pptxPfizer_Market_overview .pptx
Pfizer_Market_overview .pptx
Samson Raj Y
 
Generic drugs and their importance
Generic drugs and their importanceGeneric drugs and their importance
Generic drugs and their importance
Bishnu Koirala
 
Analysis of pharmaceutical Industry based on porters five forces model
Analysis of pharmaceutical Industry based on porters five forces model Analysis of pharmaceutical Industry based on porters five forces model
Analysis of pharmaceutical Industry based on porters five forces model
Ekankita Agrawalla
 
Remdesivir
RemdesivirRemdesivir
Your Ideal Pfizer
Your Ideal PfizerYour Ideal Pfizer
Your Ideal Pfizer
Generic Pharma 2.0
 
Para i iv orange book
Para i iv orange bookPara i iv orange book
Para i iv orange book
Altacit Global
 
Pfizer vaccines works on the covid 19 variant found in the india
Pfizer vaccines works on the covid 19 variant found in the indiaPfizer vaccines works on the covid 19 variant found in the india
Pfizer vaccines works on the covid 19 variant found in the india
rahulsingh148758
 
Dr reddy
Dr reddyDr reddy
Dr reddy
PINNUNAGARAJU
 
Sectorifics_IIMA_Pharma
Sectorifics_IIMA_PharmaSectorifics_IIMA_Pharma
Sectorifics_IIMA_Pharma
Akshay Gautam
 
" GENERIC MEDICINE''
" GENERIC MEDICINE''" GENERIC MEDICINE''
" GENERIC MEDICINE''
Ajay Baykar
 
Licencing & drug recall of 2014 & 2015
Licencing & drug recall of 2014  & 2015 Licencing & drug recall of 2014  & 2015
Licencing & drug recall of 2014 & 2015
Tahira Sultana
 
BUSINESS STARATEGY AND POLICY PROJECT
BUSINESS STARATEGY AND POLICY PROJECTBUSINESS STARATEGY AND POLICY PROJECT
BUSINESS STARATEGY AND POLICY PROJECT
ANTONIO GALVEZ SANDOVAL
 
mba 599- pfizer
mba 599- pfizermba 599- pfizer
mba 599- pfizer
michelle neeck
 
B2 novartis
B2 novartisB2 novartis
B2 novartis
Shagun Agarwal
 
Pharma Uptoday : Volume 2 issue may 2014
Pharma Uptoday : Volume 2 issue may 2014Pharma Uptoday : Volume 2 issue may 2014
Pharma Uptoday : Volume 2 issue may 2014
Sathish Vemula
 

Similar to 7 keys to open doors at Pfizer (20)

Merger & Acquisition Deal Analysis
Merger & Acquisition Deal AnalysisMerger & Acquisition Deal Analysis
Merger & Acquisition Deal Analysis
 
BioAnalysis_April 2016_Introducing The PfizerKline Empire_Raj Gunashekar
BioAnalysis_April 2016_Introducing The PfizerKline Empire_Raj GunashekarBioAnalysis_April 2016_Introducing The PfizerKline Empire_Raj Gunashekar
BioAnalysis_April 2016_Introducing The PfizerKline Empire_Raj Gunashekar
 
Pharma Spectrum by OPPI
Pharma Spectrum by OPPIPharma Spectrum by OPPI
Pharma Spectrum by OPPI
 
Case study.pptx
Case study.pptxCase study.pptx
Case study.pptx
 
ANDA FDA APPLICATION
ANDA FDA APPLICATIONANDA FDA APPLICATION
ANDA FDA APPLICATION
 
Pfizer_Market_overview .pptx
Pfizer_Market_overview .pptxPfizer_Market_overview .pptx
Pfizer_Market_overview .pptx
 
Generic drugs and their importance
Generic drugs and their importanceGeneric drugs and their importance
Generic drugs and their importance
 
Analysis of pharmaceutical Industry based on porters five forces model
Analysis of pharmaceutical Industry based on porters five forces model Analysis of pharmaceutical Industry based on porters five forces model
Analysis of pharmaceutical Industry based on porters five forces model
 
Remdesivir
RemdesivirRemdesivir
Remdesivir
 
Your Ideal Pfizer
Your Ideal PfizerYour Ideal Pfizer
Your Ideal Pfizer
 
Para i iv orange book
Para i iv orange bookPara i iv orange book
Para i iv orange book
 
Pfizer vaccines works on the covid 19 variant found in the india
Pfizer vaccines works on the covid 19 variant found in the indiaPfizer vaccines works on the covid 19 variant found in the india
Pfizer vaccines works on the covid 19 variant found in the india
 
Dr reddy
Dr reddyDr reddy
Dr reddy
 
Sectorifics_IIMA_Pharma
Sectorifics_IIMA_PharmaSectorifics_IIMA_Pharma
Sectorifics_IIMA_Pharma
 
" GENERIC MEDICINE''
" GENERIC MEDICINE''" GENERIC MEDICINE''
" GENERIC MEDICINE''
 
Licencing & drug recall of 2014 & 2015
Licencing & drug recall of 2014  & 2015 Licencing & drug recall of 2014  & 2015
Licencing & drug recall of 2014 & 2015
 
BUSINESS STARATEGY AND POLICY PROJECT
BUSINESS STARATEGY AND POLICY PROJECTBUSINESS STARATEGY AND POLICY PROJECT
BUSINESS STARATEGY AND POLICY PROJECT
 
mba 599- pfizer
mba 599- pfizermba 599- pfizer
mba 599- pfizer
 
B2 novartis
B2 novartisB2 novartis
B2 novartis
 
Pharma Uptoday : Volume 2 issue may 2014
Pharma Uptoday : Volume 2 issue may 2014Pharma Uptoday : Volume 2 issue may 2014
Pharma Uptoday : Volume 2 issue may 2014
 

More from databahn

Manulife Org Chart & Sales Intelligence Presentation.pptx
Manulife Org Chart & Sales Intelligence Presentation.pptxManulife Org Chart & Sales Intelligence Presentation.pptx
Manulife Org Chart & Sales Intelligence Presentation.pptx
databahn
 
2020 Fortune 1000 list factoids and findings
2020 Fortune 1000 list factoids and findings2020 Fortune 1000 list factoids and findings
2020 Fortune 1000 list factoids and findings
databahn
 
Fortune 1000 companies' response to covid 19
Fortune 1000 companies' response to covid 19Fortune 1000 companies' response to covid 19
Fortune 1000 companies' response to covid 19
databahn
 
Industries and Fortune 1000 companies thriving during the global pandemic
Industries and Fortune 1000 companies thriving during the global pandemicIndustries and Fortune 1000 companies thriving during the global pandemic
Industries and Fortune 1000 companies thriving during the global pandemic
databahn
 
7 keys to open doors at Cigna
7 keys to open doors at Cigna7 keys to open doors at Cigna
7 keys to open doors at Cigna
databahn
 
7 keys to open doors at Goldman Sachs
7 keys to open doors at Goldman Sachs7 keys to open doors at Goldman Sachs
7 keys to open doors at Goldman Sachs
databahn
 
7 keys to open doors at Sysco
7 keys to open doors at Sysco7 keys to open doors at Sysco
7 keys to open doors at Sysco
databahn
 
7 keys to open doors at Caterpillar
7 keys to open doors at Caterpillar7 keys to open doors at Caterpillar
7 keys to open doors at Caterpillar
databahn
 
7 keys to open doors at Walt Disney
7 keys to open doors at Walt Disney7 keys to open doors at Walt Disney
7 keys to open doors at Walt Disney
databahn
 
7 keys to open doors at PepsiCo
7 keys to open doors at PepsiCo7 keys to open doors at PepsiCo
7 keys to open doors at PepsiCo
databahn
 
7 keys to open doors at FedEx
7 keys to open doors at FedEx7 keys to open doors at FedEx
7 keys to open doors at FedEx
databahn
 
7 keys to open doors at Procter & Gamble
7 keys to open doors at Procter & Gamble7 keys to open doors at Procter & Gamble
7 keys to open doors at Procter & Gamble
databahn
 
7 keys to open doors at MetLife
7 keys to open doors at MetLife7 keys to open doors at MetLife
7 keys to open doors at MetLife
databahn
 
7 keys to open doors at Lowe's
7 keys to open doors at Lowe's7 keys to open doors at Lowe's
7 keys to open doors at Lowe's
databahn
 
7 keys to open doors at UPS
7 keys to open doors at UPS7 keys to open doors at UPS
7 keys to open doors at UPS
databahn
 
7 keys to open doors at Wells Fargo
7 keys to open doors at Wells Fargo7 keys to open doors at Wells Fargo
7 keys to open doors at Wells Fargo
databahn
 
7 keys to open doors at Microsoft
7 keys to open doors at Microsoft7 keys to open doors at Microsoft
7 keys to open doors at Microsoft
databahn
 
7 keys to open doors at Johnson & Johnson
7 keys to open doors at Johnson & Johnson7 keys to open doors at Johnson & Johnson
7 keys to open doors at Johnson & Johnson
databahn
 
7 keys to open doors at Starbucks
7 keys to open doors at Starbucks7 keys to open doors at Starbucks
7 keys to open doors at Starbucks
databahn
 
7 keys to open doors at Valero Energy
7 keys to open doors at Valero Energy7 keys to open doors at Valero Energy
7 keys to open doors at Valero Energy
databahn
 

More from databahn (20)

Manulife Org Chart & Sales Intelligence Presentation.pptx
Manulife Org Chart & Sales Intelligence Presentation.pptxManulife Org Chart & Sales Intelligence Presentation.pptx
Manulife Org Chart & Sales Intelligence Presentation.pptx
 
2020 Fortune 1000 list factoids and findings
2020 Fortune 1000 list factoids and findings2020 Fortune 1000 list factoids and findings
2020 Fortune 1000 list factoids and findings
 
Fortune 1000 companies' response to covid 19
Fortune 1000 companies' response to covid 19Fortune 1000 companies' response to covid 19
Fortune 1000 companies' response to covid 19
 
Industries and Fortune 1000 companies thriving during the global pandemic
Industries and Fortune 1000 companies thriving during the global pandemicIndustries and Fortune 1000 companies thriving during the global pandemic
Industries and Fortune 1000 companies thriving during the global pandemic
 
7 keys to open doors at Cigna
7 keys to open doors at Cigna7 keys to open doors at Cigna
7 keys to open doors at Cigna
 
7 keys to open doors at Goldman Sachs
7 keys to open doors at Goldman Sachs7 keys to open doors at Goldman Sachs
7 keys to open doors at Goldman Sachs
 
7 keys to open doors at Sysco
7 keys to open doors at Sysco7 keys to open doors at Sysco
7 keys to open doors at Sysco
 
7 keys to open doors at Caterpillar
7 keys to open doors at Caterpillar7 keys to open doors at Caterpillar
7 keys to open doors at Caterpillar
 
7 keys to open doors at Walt Disney
7 keys to open doors at Walt Disney7 keys to open doors at Walt Disney
7 keys to open doors at Walt Disney
 
7 keys to open doors at PepsiCo
7 keys to open doors at PepsiCo7 keys to open doors at PepsiCo
7 keys to open doors at PepsiCo
 
7 keys to open doors at FedEx
7 keys to open doors at FedEx7 keys to open doors at FedEx
7 keys to open doors at FedEx
 
7 keys to open doors at Procter & Gamble
7 keys to open doors at Procter & Gamble7 keys to open doors at Procter & Gamble
7 keys to open doors at Procter & Gamble
 
7 keys to open doors at MetLife
7 keys to open doors at MetLife7 keys to open doors at MetLife
7 keys to open doors at MetLife
 
7 keys to open doors at Lowe's
7 keys to open doors at Lowe's7 keys to open doors at Lowe's
7 keys to open doors at Lowe's
 
7 keys to open doors at UPS
7 keys to open doors at UPS7 keys to open doors at UPS
7 keys to open doors at UPS
 
7 keys to open doors at Wells Fargo
7 keys to open doors at Wells Fargo7 keys to open doors at Wells Fargo
7 keys to open doors at Wells Fargo
 
7 keys to open doors at Microsoft
7 keys to open doors at Microsoft7 keys to open doors at Microsoft
7 keys to open doors at Microsoft
 
7 keys to open doors at Johnson & Johnson
7 keys to open doors at Johnson & Johnson7 keys to open doors at Johnson & Johnson
7 keys to open doors at Johnson & Johnson
 
7 keys to open doors at Starbucks
7 keys to open doors at Starbucks7 keys to open doors at Starbucks
7 keys to open doors at Starbucks
 
7 keys to open doors at Valero Energy
7 keys to open doors at Valero Energy7 keys to open doors at Valero Energy
7 keys to open doors at Valero Energy
 

Recently uploaded

Advertising and Promotion of whisper by Sakthi Sundar
Advertising and Promotion of whisper by Sakthi SundarAdvertising and Promotion of whisper by Sakthi Sundar
Advertising and Promotion of whisper by Sakthi Sundar
sakthisundar2001
 
Snapshot of Consumer Behaviors of May 2024-EOLiSurvey (EN).pdf
Snapshot of Consumer Behaviors of May 2024-EOLiSurvey (EN).pdfSnapshot of Consumer Behaviors of May 2024-EOLiSurvey (EN).pdf
Snapshot of Consumer Behaviors of May 2024-EOLiSurvey (EN).pdf
Eastern Online-iSURVEY
 
一比一原版澳洲纽卡斯尔大学毕业证(UoN学位证)如何办理
一比一原版澳洲纽卡斯尔大学毕业证(UoN学位证)如何办理一比一原版澳洲纽卡斯尔大学毕业证(UoN学位证)如何办理
一比一原版澳洲纽卡斯尔大学毕业证(UoN学位证)如何办理
10h6bbc4
 
E-Learning Vs Traditional Learning_ Benefits and Differences.pdf
E-Learning Vs Traditional Learning_ Benefits and Differences.pdfE-Learning Vs Traditional Learning_ Benefits and Differences.pdf
E-Learning Vs Traditional Learning_ Benefits and Differences.pdf
Mega P
 
How to Generate Add to Calendar Link using Cal.et
How to Generate Add to Calendar Link using Cal.etHow to Generate Add to Calendar Link using Cal.et
How to Generate Add to Calendar Link using Cal.et
Y
 
2025 Adventur ehomes Product Guide released Jun 1 2024
2025 Adventur ehomes Product Guide released Jun 1 20242025 Adventur ehomes Product Guide released Jun 1 2024
2025 Adventur ehomes Product Guide released Jun 1 2024
JimWilliams206540
 
The Future of B2B Audience Targeting with LinkedIn
The Future of B2B Audience Targeting with LinkedInThe Future of B2B Audience Targeting with LinkedIn
The Future of B2B Audience Targeting with LinkedIn
Tajul Islam
 
Top 10 AI Trends to Watch in 2024 with Intelisync
Top 10 AI Trends to Watch in 2024 with IntelisyncTop 10 AI Trends to Watch in 2024 with Intelisync
Top 10 AI Trends to Watch in 2024 with Intelisync
nehapardhi711
 
Transforming Digital Marketing with Top AI Tools of 2024.pdf
Transforming Digital Marketing with Top AI Tools of 2024.pdfTransforming Digital Marketing with Top AI Tools of 2024.pdf
Transforming Digital Marketing with Top AI Tools of 2024.pdf
Tirupati Gayaph
 
Growth Marketing Portfolio - Priyanka Srivastava
Growth Marketing Portfolio - Priyanka SrivastavaGrowth Marketing Portfolio - Priyanka Srivastava
Growth Marketing Portfolio - Priyanka Srivastava
PriyankaSrivastava508477
 
2024 Trend Updates: What Really Works In SEO & Content Marketing
2024 Trend Updates: What Really Works In SEO & Content Marketing2024 Trend Updates: What Really Works In SEO & Content Marketing
2024 Trend Updates: What Really Works In SEO & Content Marketing
Search Engine Journal
 
BEST DIGITAL MARKETING AGENCY IN BANGALORE
BEST DIGITAL MARKETING AGENCY IN BANGALOREBEST DIGITAL MARKETING AGENCY IN BANGALORE
BEST DIGITAL MARKETING AGENCY IN BANGALORE
ManuDv1
 
一比一原版澳洲悉尼大学毕业证(USYD学位证)如何办理
一比一原版澳洲悉尼大学毕业证(USYD学位证)如何办理一比一原版澳洲悉尼大学毕业证(USYD学位证)如何办理
一比一原版澳洲悉尼大学毕业证(USYD学位证)如何办理
10h6bbc4
 
一比一原版英国南安普顿大学毕业证(Soton学位证)如何办理
一比一原版英国南安普顿大学毕业证(Soton学位证)如何办理一比一原版英国南安普顿大学毕业证(Soton学位证)如何办理
一比一原版英国南安普顿大学毕业证(Soton学位证)如何办理
dqvc9xf1
 
DCC Technology Intro Slides June 2024.pptx
DCC Technology Intro Slides June 2024.pptxDCC Technology Intro Slides June 2024.pptx
DCC Technology Intro Slides June 2024.pptx
vishc81
 
Customer relationship management notes for Bcom students
Customer relationship management notes for Bcom studentsCustomer relationship management notes for Bcom students
Customer relationship management notes for Bcom students
PratibhaShelake1
 
Title: Making Money the Easy Way: A Quick Guide to Generating Income
Title: Making Money the Easy Way: A Quick Guide to Generating IncomeTitle: Making Money the Easy Way: A Quick Guide to Generating Income
Title: Making Money the Easy Way: A Quick Guide to Generating Income
WilliamZinsmeister
 
SEO and Google Ads Fundamentals Gokce Yesilbas
SEO and Google Ads Fundamentals Gokce YesilbasSEO and Google Ads Fundamentals Gokce Yesilbas
SEO and Google Ads Fundamentals Gokce Yesilbas
gokceyesilbas
 
AI Best Practices for Marketing HUG June 2024
AI Best Practices for Marketing HUG June 2024AI Best Practices for Marketing HUG June 2024
AI Best Practices for Marketing HUG June 2024
Amanda Farrell
 
Social Samosa's #30Under30 Guidebook.pdf
Social Samosa's #30Under30 Guidebook.pdfSocial Samosa's #30Under30 Guidebook.pdf
Social Samosa's #30Under30 Guidebook.pdf
Social Samosa
 

Recently uploaded (20)

Advertising and Promotion of whisper by Sakthi Sundar
Advertising and Promotion of whisper by Sakthi SundarAdvertising and Promotion of whisper by Sakthi Sundar
Advertising and Promotion of whisper by Sakthi Sundar
 
Snapshot of Consumer Behaviors of May 2024-EOLiSurvey (EN).pdf
Snapshot of Consumer Behaviors of May 2024-EOLiSurvey (EN).pdfSnapshot of Consumer Behaviors of May 2024-EOLiSurvey (EN).pdf
Snapshot of Consumer Behaviors of May 2024-EOLiSurvey (EN).pdf
 
一比一原版澳洲纽卡斯尔大学毕业证(UoN学位证)如何办理
一比一原版澳洲纽卡斯尔大学毕业证(UoN学位证)如何办理一比一原版澳洲纽卡斯尔大学毕业证(UoN学位证)如何办理
一比一原版澳洲纽卡斯尔大学毕业证(UoN学位证)如何办理
 
E-Learning Vs Traditional Learning_ Benefits and Differences.pdf
E-Learning Vs Traditional Learning_ Benefits and Differences.pdfE-Learning Vs Traditional Learning_ Benefits and Differences.pdf
E-Learning Vs Traditional Learning_ Benefits and Differences.pdf
 
How to Generate Add to Calendar Link using Cal.et
How to Generate Add to Calendar Link using Cal.etHow to Generate Add to Calendar Link using Cal.et
How to Generate Add to Calendar Link using Cal.et
 
2025 Adventur ehomes Product Guide released Jun 1 2024
2025 Adventur ehomes Product Guide released Jun 1 20242025 Adventur ehomes Product Guide released Jun 1 2024
2025 Adventur ehomes Product Guide released Jun 1 2024
 
The Future of B2B Audience Targeting with LinkedIn
The Future of B2B Audience Targeting with LinkedInThe Future of B2B Audience Targeting with LinkedIn
The Future of B2B Audience Targeting with LinkedIn
 
Top 10 AI Trends to Watch in 2024 with Intelisync
Top 10 AI Trends to Watch in 2024 with IntelisyncTop 10 AI Trends to Watch in 2024 with Intelisync
Top 10 AI Trends to Watch in 2024 with Intelisync
 
Transforming Digital Marketing with Top AI Tools of 2024.pdf
Transforming Digital Marketing with Top AI Tools of 2024.pdfTransforming Digital Marketing with Top AI Tools of 2024.pdf
Transforming Digital Marketing with Top AI Tools of 2024.pdf
 
Growth Marketing Portfolio - Priyanka Srivastava
Growth Marketing Portfolio - Priyanka SrivastavaGrowth Marketing Portfolio - Priyanka Srivastava
Growth Marketing Portfolio - Priyanka Srivastava
 
2024 Trend Updates: What Really Works In SEO & Content Marketing
2024 Trend Updates: What Really Works In SEO & Content Marketing2024 Trend Updates: What Really Works In SEO & Content Marketing
2024 Trend Updates: What Really Works In SEO & Content Marketing
 
BEST DIGITAL MARKETING AGENCY IN BANGALORE
BEST DIGITAL MARKETING AGENCY IN BANGALOREBEST DIGITAL MARKETING AGENCY IN BANGALORE
BEST DIGITAL MARKETING AGENCY IN BANGALORE
 
一比一原版澳洲悉尼大学毕业证(USYD学位证)如何办理
一比一原版澳洲悉尼大学毕业证(USYD学位证)如何办理一比一原版澳洲悉尼大学毕业证(USYD学位证)如何办理
一比一原版澳洲悉尼大学毕业证(USYD学位证)如何办理
 
一比一原版英国南安普顿大学毕业证(Soton学位证)如何办理
一比一原版英国南安普顿大学毕业证(Soton学位证)如何办理一比一原版英国南安普顿大学毕业证(Soton学位证)如何办理
一比一原版英国南安普顿大学毕业证(Soton学位证)如何办理
 
DCC Technology Intro Slides June 2024.pptx
DCC Technology Intro Slides June 2024.pptxDCC Technology Intro Slides June 2024.pptx
DCC Technology Intro Slides June 2024.pptx
 
Customer relationship management notes for Bcom students
Customer relationship management notes for Bcom studentsCustomer relationship management notes for Bcom students
Customer relationship management notes for Bcom students
 
Title: Making Money the Easy Way: A Quick Guide to Generating Income
Title: Making Money the Easy Way: A Quick Guide to Generating IncomeTitle: Making Money the Easy Way: A Quick Guide to Generating Income
Title: Making Money the Easy Way: A Quick Guide to Generating Income
 
SEO and Google Ads Fundamentals Gokce Yesilbas
SEO and Google Ads Fundamentals Gokce YesilbasSEO and Google Ads Fundamentals Gokce Yesilbas
SEO and Google Ads Fundamentals Gokce Yesilbas
 
AI Best Practices for Marketing HUG June 2024
AI Best Practices for Marketing HUG June 2024AI Best Practices for Marketing HUG June 2024
AI Best Practices for Marketing HUG June 2024
 
Social Samosa's #30Under30 Guidebook.pdf
Social Samosa's #30Under30 Guidebook.pdfSocial Samosa's #30Under30 Guidebook.pdf
Social Samosa's #30Under30 Guidebook.pdf
 

7 keys to open doors at Pfizer

  • 1.
  • 2.  The new initiative is focused on gene therapy. Pfizer operates a gene therapy research facility at the Sanford complex.  “The new facility will help advance Pfizer’s work in researching highly specialized, potentially one-time gene therapy treatments that use custom- made adeno-associated virus (AAV) vectors to deliver treatment effectively to patients” according to Pfizer. Pfizer to announce more jobs, investment at Sanford, NC plant
  • 3.  Pfizer, the world’s largest drugmaker, plans to divest its off-patent drug business and combine it with generic-drug maker Mylan.  Under the agreement, which is structured as an all-stock deal, each Mylan share would be converted into one share of the new company.  Pfizer shareholders would own 57% of the combined new company and Mylan shareholders would own 43%, Mylan said. Pfizer will combine its off-patent drug business with Mylan
  • 4.  Pfizer announced in mid-June that it would buy Array (ARRY) in a deal worth a reported $10.6 billion. Pfizer acquires Array BioPharma
  • 5.  The FDA has approved Pfizer’s rituximab biosimilar, Ruxience (rituximab-pvvr), referencing Rituxan. The biosimilar was approved to treat non-Hodgkin lymphoma, chronic lymphocytic leukemia, and granulomatosis with polyangiitis and microscopic polyangiitis.  The fact that the biosimilar was not approved for all indications of its reference, a Pfizer representative told The Center for Biosimilars® in an email, is due to the fact that “Genentech has exclusivity for rituximab in certain indications. Pfizer has agreed to the terms of a global settlement,” but “specific terms and conditions of the settlement are confidential.” FDA Approves Pfizer's Rituximab Biosimilar, Ruxience
  • 6.  Pfizer Inc said it acquired a 15 percent stake in Vivet Therapeutics, as well as an exclusive option to fully acquire it, a deal that will give it access to the French company’s experimental gene therapy for a rare genetic disorder called Wilson disease.  Pfizer has paid Vivet about $51 million upfront and may pay up to $635.8 million in clinical, regulatory milestone payments and to exercise the option to buy the whole company. Pfizer buys stake in French gene therapy firm Vivet
  • 7.  The U.S. Food and Drug Administration approved Pfizer Inc’s oral drug, tafamidis, to treat a rare and fatal heart disease called transthyretin amyloid cardiomyopathy.  Pfizer, which has touted tafamidis as a potential blockbuster product, set a list price of $225,000 a year for the medicine, which would be sold under the brand name Vyndaqel. The U.S. Food and Drug Administration approved Pfizer Inc’s oral drug, tafamidis
  • 8.  More than three years after snapping up Hospira, Pfizer has finally decided that some of its manufacturing facilities in India are beyond redemption.  The U.S. pharma will shut down its long-troubled injectables facility in Irungattukottai, India, as well as another site in Aurangabad, India, both of which were folded into Pfizer through the $15 billion acquisition of Hospira in 2015. Pfizer will shut down its injectables facility in Irungattukottai, India, as well as another site in Aurangabad, India
  • 9. The Pfizer TURBO report has dozens of pages of customer insights compiled to help you sell and market more effectively. FORTUNE 500 TURBO REPORTS 844.DATABAHN 844.328.2224 ext. 707 info@databahn.com www.databahn.com We help sales reps and marketers eliminate costly research time and uncover new sales pipeline opportunities. Please visit www.databahn.com/page/turbo to download a TURBO Fortune 500 company profile report (PDF). We also build custom deep dive Fortune 1000 company profile reports. Please contact us if you need help.